BioLife Solutions, Inc. (BLFS)
$38.61+0.00%Close
BUYBULL · day 72
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.9B
- Beta
- 1.92
- P/E (TTM)
- 37.34
- Short % float
- 9.37%
- Days to cover
- 4.3
- SI change
- +3.0%
- 1W
- -1.56%
- 1M
- +9.53%
- vs SPY 1W
- -1.42%
- vs SPY 1M
- +7.03%
Industry peers
FMP comparable companies · ranked by market cap
- WSTBUYWest Pharmaceutical Services, Inc.$25.6BBULLQ 20$363.27+1.15%
- TECHBUYBio-Techne Corporation$11.3BBULLQ 19$72.45-0.11%
- RGENSELLRepligen Corporation$9.2BBEARQ 26$163.84+1.69%
- MRVISELLMaravai LifeSciences Holdings, Inc.$2.0BCRISISQ -2$7.21-7.51%
- AZTABUYAzenta, Inc.$1.7BRECOVERYQ 9$36.00+0.26%
- CYRXBUYCryoport, Inc.$852MBEARQ 6$16.90+0.65%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BLFS?
- LOPJLB’s latest quantitative signal on BioLife Solutions, Inc. (BLFS) is BUY in a BULL regime. Signals are updated daily.
- What market regime is BLFS in?
- BioLife Solutions, Inc. (BLFS) is currently classified in the BULL HMM market regime on LOPJLB.
- What does BioLife Solutions, Inc. (BLFS) do?
- BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning…